Legal & General Group Plc - LOGICBIO THERAPEUTICS INC ownership

LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 44 filers reported holding LOGICBIO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of LOGICBIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$14,000
-12.5%
1,961
-4.6%
0.00%
Q4 2020$16,000
+14.3%
2,056
+36.4%
0.00%
Q3 2020$14,000
-22.2%
1,507
-29.2%
0.00%
Q2 2020$18,000
+125.0%
2,130
+30.6%
0.00%
Q1 2020$8,000
-33.3%
1,6310.0%0.00%
Q4 2019$12,000
-14.3%
1,631
+29.5%
0.00%
Q3 2019$14,000
-12.5%
1,2590.0%0.00%
Q2 2019$16,000
+33.3%
1,2590.0%0.00%
Q1 2019$12,000
-7.7%
1,2590.0%0.00%
Q4 2018$13,0001,2590.00%
Other shareholders
LOGICBIO THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Lion Point Capital, LP 500,000$2,220,0000.38%
Orbimed Advisors 8,466,783$37,593,0000.38%
Sio Capital Management, LLC 182,630$811,0000.20%
Tibra Equities Europe Ltd 76,500$340,0000.10%
SAMLYN CAPITAL, LLC 1,420,452$6,308,0000.09%
PURA VIDA INVESTMENTS, LLC 249,256$1,107,0000.03%
Trexquant Investment LP 46,229$205,0000.02%
SANDERS MORRIS HARRIS LLC 15,000$67,0000.01%
Baker Brothers Advisors 451,478$2,005,0000.01%
Verition Fund Management LLC 208,099$924,0000.01%
View complete list of LOGICBIO THERAPEUTICS INC shareholders